glp 1 multiple sclerosis A Phase 2 trial just began testing whether a GLP-1 drug can slow brain shrinkage status:live-noLabs-noHCC-detoxInclude How pharmacists can support Size:6 Pack

glp 1 multiple sclerosis A Phase 2 trial just began testing whether a GLP-1 drug can slow brain shrinkage status:live-noLabs-noHCC-detoxInclude How pharmacists can support Size:6 Pack

How pharmacists can support GLP-1 adherence

If you’ve recovered from bulimia and self-purging behaviors, yet the nausea, vomiting, or feelings of fullness you experience from GLP-1 use triggers thoughts and urges to purge again, get in touch with your prescribing provider and an eating disorder professional

status:live-noLabs-noHCC-detoxInclude

Size:6 Pack

Ocrevus (ocrelizumab) Disease area(s): Neurology/immunology Manufacturer(s): Roche 2024 Sales (USD): $7.66 billion Why it sold so well: In 2024, Roche’s multiple sclerosis (MS) therapy Ocrevus achieved sales of CHF 6.74 billion ($7.66 billion), marking a 9% increase from the previous year